LABCORP HOLDINGS INC. — Director's Dealing 2016

Oct 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-10-03

Reporting Person: Ratliff John D (CEO, Covance Drug Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-03	Restricted Stock Unit	$	A	18300	Acquired		Common Stock (18300)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17.